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Bacterial vaginosis (BV) is characterized by a shift in
vaginal flora, with a decrease in the prevalence of Lacto-
bacillus and an increase in the prevalence and concentra-
tion of anaerobic bacteria, Gardnerella vaginalis, and
Mycoplasma hominis. BV, which is consistently associated
with preterm delivery,1,2 is also associated with first- and
second-trimester miscarriage,3,4 amniotic fluid infec-
tion,5,6 histologic chorioamnionitis,7 and postpartum en-
dometritis.8 The consistent associations between BV and
these markers of upper genital tract infection provide
strong indirect evidence that abnormal vaginal flora can
ascend to cause bacterial upper genital tract infection
and preterm birth. However, most pregnant women with
BV have normal pregnancy outcomes.
The presence and concentrations of microbial hy-
drolytic enzymes in women with BV vary. Sialidases (or
neuraminidases) are glycosylases that are produced in
vitro by several BV-associated bacteria.9 Prolidase (or pro-
line aminopeptidase) is another hydrolytic enzyme pro-
duced by BV-associated bacteria, including G vaginalis
and Mobiluncus spp.10
The only characterized immunogenic virulence factor
found in BV thus far is the G vaginalis hemolytic toxin
(Gvh).11,12 The production and concentration of im-
munoglobulin A (IgA) in response to Gvh in women with
BV also vary. Low levels of anti-Gvh IgA in women with BV
who are not pregnant are correlated with high levels of
vaginal sialidase activity13 and with cleavage of IgA in vagi-
nal fluid.14
It remains to be established whether different profiles
of these biochemical markers correspond to different lev-
els of risk for poor pregnancy outcome. In the present
study, we examined the hypothesis that an increased con-
centration of sialidase and prolidase and a decreased con-
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OBJECTIVE: The purpose of this study was to determine whether the microbial hydrolytic enzymes, siali-
dase and prolidase, and immunoglobulin A against the Gardnerella vaginalis cytolysin (anti-Gvh IgA) in-
crease the risk for early preterm birth (≤34 weeks of gestation) among women with bacterial vaginosis or
intermediate flora.
STUDY DESIGN: Two hundred eighteen afebrile women in preterm labor with intact membranes had a vagi-
nal Gram stain performed, and sialidase, prolidase, and anti-Gvh IgA concentrations were determined.
RESULTS: Women with bacterial vaginosis or intermediate flora had significantly higher sialidase and proli-
dase concentrations than women with normal flora. Among women with bacterial vaginosis or intermediate
flora, the women with sialidase had a higher rate of early preterm birth (P = .05). Sialidase had a sensitivity
of 43% and specificity of 77% for early preterm birth. Prolidase and anti-Gvh IgA did not predict early preterm
birth.
CONCLUSION: Women in preterm labor with bacterial vaginosis or intermediate flora and detectable siali-
dase are at increased risk of early preterm birth. (Am J Obstet Gynecol 2002;187:877-81.)
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centration of anti-Gvh IgA would be associated with an in-
creased risk of early preterm birth among women in pre-
term labor with BV or intermediate vaginal flora.
Material and methods
The study population included 218 afebrile women
who were admitted in premature labor with intact mem-
branes to the University of Washington Medical Center or
Swedish Medical Center in Seattle between June 1991
and June 1997. All women provided written informed
consent for study participation, and the Institutional Re-
view Boards of all participating hospitals approved the
study protocol. Participants were at gestational ages of 20
to 34 weeks by obstetric estimate, which was determined
from menstrual dating or from the earliest available ul-
trasound imaging. Preterm labor was defined as regular
uterine contractions at a frequency of <10 minutes, with
either documented cervical change or a cervical dilata-
tion of >1 cm or effacement of >50%. The study popula-
tion was previously been described in detail.15 Of 310
participants, 11 women (4%) were lost to follow-up, 12
women (4%) were excluded because of major congenital
anomalies or higher-order multiple gestation, 8 women
(3%) refused speculum examination, 17 women (5%)
had the speculum examination omitted because of immi-
nent delivery, and 44 women (14%) did not have suffi-
cient vaginal fluid for analysis. The remaining 218
subjects had vaginal fluid samples available for these
analyses.
Vaginal specimens were obtained by saturating six Pur
Wrap (Harwood Products Co, Guildford, Me) swabs with
fluid from the posterior vaginal fornix. One swab was
used for a Gram stain of the vaginal flora. Vaginal flora
was characterized by Gram stain as normal flora, inter-
mediate flora, or BV, according to published criteria.16
Samples of vaginal fluid to measure biochemical para-
meters were collected with three saturated swabs, inocu-
lated into 0.9 mL of sterile phosphate-buffered saline
solution (sodium chloride 0.9%), and immediately
frozen to –70°C. Sialidase activity was determined by in-
cubation of 50 µL of the vaginal sample with 50 µL of the
specific substrate at pH 5.0, as previously described.13
Specific activity was expressed as nanomoles of
methoxyphenol that was produced by comparison with a
standard curve of pure methoxyphenol. Positive sialidase
activity was considered to be any detectable level >0.04
nmol of methoxyphenol.
Prolidase activity was determined as previously de-
scribed.14 Absorbance (mOD) was read at 405 nm. Posi-
tive prolidase activity was considered as any detectable
level >5 mOD. Four samples were not interpretable;
therefore, prolidase results were available for 214 of 218
participants.
The anti-Gvh IgA concentration was evaluated accord-
ing to an enzyme-linked immunosorbent assay procedure
that has been previously described.14 The lower limit of
detection was 5 mOD. A cutoff value of 94 mOD was
based on the 50th percentile of the anti-Gvh IgA levels
Table I. Demographic and reproductive characteristics and pregnancy outcomes for women with BV and intermediate
and normal flora, by Gram stain
BV Intermediate flora Normal flora
Characteristic/outcome (n = 31) (n = 66) (n = 121)
Age (y)
Median 24 23 26
Range 15-36 16-42 15-43
Racial group (No.)
White 18 (58%) 40 (61%) 81 (67%)
Black 6 (19%) 12 (18%) 20 (16.5%)
Other 7 (23%) 14 (21%) 20 (16.5%)
Cigarette smoker (No.) 4 (13%) 14 (22%) 21 (18%)
Nulliparity (No.) 13 (42%) 27 (42%) 55 (46%)
Previous preterm delivery for parous women (No.) 8/18 (44%) 14/39 (36%) 32/66 (48%)
Weeks of gestation at enrollment (No.)*
Median 28 30.5 32
Range 20-34 23-34 22-34
Days from enrollment to delivery (No.)
Median 12 14 21
Range 1-110 1-129 1-129
Weeks of gestation at delivery (No.)*
Median 31 33.5 36
Range 21-39 23-41 23-41
Infant birth weight (g)†
Median 1580 2261 2581
Range 482-4107 596-3739 553-4369
*P < .001, by Kruskal-Wallis analysis of variance.
†P = .008, by Kruskal-Wallis analysis of variance.
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that were measured in the 85 women from this data set
who had a normal Gram stain and no G vaginalis by cul-
ture. We defined anti-Gvh IgA values at or below the
threshold value of 94 mOD as the low IgA response, and
values of >94 mOD were considered as high IgA response.
We compared categoric variables using the χ2 or Fisher
exact test. The Mann-Whitney test and Kruskal-Wallis
analysis of variance were used to compare groups for con-
tinuous data; the Bonferroni correction for multiple
comparisons was used to examine differences between
the BV and intermediate flora groups in pregnancy out-
comes. Early preterm birth was defined as delivery at ≤34
weeks of gestation. We examined the associations be-
tween sialidase, prolidase, and anti-Gvh IgA with early
preterm birth among the subset of women with BV or in-
termediate flora. We also calculated the sensitivity, speci-
ficity, and positive and negative predictive values of each
of these biochemical markers for early preterm birth
among the subset with BV or intermediate flora.
Results
Of 218 participants in preterm labor, 31 women (14%)
had BV, and 66 women (30%) had intermediate vaginal
flora, by Gram stain criteria. Table I gives a summary of
the demographic and reproductive characteristics and
pregnancy outcomes, which were stratified by Gram stain
findings. Compared with women with normal flora,
women with BV or intermediate flora presented and were
delivered at an earlier gestational age. There were no sta-
tistically significant differences between women with BV
and intermediate flora, with respect to gestational age at
delivery or infant birth weight.
Fig 1 shows the sialidase, prolidase, and anti-Gvh IgA
concentrations for women with normal flora, intermedi-
ate flora, or BV by Gram stain criteria. Sialidase and prol-
idase concentrations were significantly higher among the
BV and intermediate flora groups, compared with the
normal flora group (P < .001, by global Kruskal-Wallis
analysis for both enzymes). Anti-Gvh IgA concentrations
were lower in the BV and intermediate flora groups than
in the normal flora group, but this did not reach statisti-
cal significance.
We examined the relationships between sialidase and
prolidase concentrations and IgA response by a catego-
rization of anti-Gvh concentrations as low or high, using a
cutoff value of 94 mOD (median value for women with a
normal Gram stain, Fig 2). For women with BV or inter-
mediate flora, sialidase (P = .03) and prolidase (P = .04)
concentrations were significantly higher among the
group with a low IgA response. However, among women
with a normal Gram stain, there was no significant differ-
ence in sialidase and prolidase concentrations in relation
to IgA response (data not shown).
Of 218 women, 105 women (48%) had an early pre-
term birth. Delivery at ≤34 weeks occurred in 58 of 97
women (60%) with BV or intermediate flora compared
with 47 of 121 women (39%) with a normal Gram stain 
(P = .003). We examined the associations between siali-
dase, prolidase, and anti-Gvh IgA response and early pre-
term birth in the subset of women with BV or
intermediate flora. Early preterm birth occurred in 25 of
34 women (74%) with BV or intermediate flora and siali-
dase detected in vaginal fluid compared with 33 of 63
women (52%) with BV or intermediate flora but no de-
tectable sialidase (P = .05). Among women with BV or in-
termediate flora, sialidase had a sensitivity of 43%,
specificity of 77%, positive predictive value of 74%, and
negative predictive value of 48% for early preterm birth
Fig 1. Sialidase, prolidase, and anti-Gvh IgA concentrations, according to vaginal Gram stain category. Statistical signifi-
cance was determined by Kruskal-Wallis analysis of variance.
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(Table II). Prolidase and a low anti-Gvh IgA concentra-
tion were not predictive of early preterm birth.
Comment
Women with BV or intermediate flora in this cohort
had preterm labor at an earlier gestational age and were
delivered at an earlier gestational age compared with
women with normal vaginal flora. These observations
agree with other studies that show an association between
BV and preterm birth.1,2
We also confirmed that pregnant women with BV or in-
termediate flora have higher concentrations of sialidase
and prolidase, two microbial hydrolytic enzymes that are
produced by BV-associated bacteria, than do women with
normal vaginal flora. In addition, pregnant women with
BV or intermediate flora appear to have lower anti-Gvh
Fig 2. Sialidase and prolidase concentrations, according to anti-Gvh IgA category, among women with BV or intermedi-
ate flora. Statistical significance was determined by the Mann-Whitney test.
Table II. Sensitivity, specificity, and positive and negative predictive values of sialidase, prolidase, and anti-Gvh IgA for
the prediction of delivery at ≤34 weeks, among women with BV or intermediate flora
Positive values/ Sensitivity Specificity Positive predictive Negative predictive 
women tested (No.) (%) (%) value (%) value (%)
Sialidase detected 34/97 (35%) 43 77 74 48
Prolidase detected 60/95 (63%) 62 36 58 40
Anti-Gvh IgA ≤94 mOD 60/97 (62%) 60 36 58 37
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IgA concentrations than do women with normal flora, al-
though this finding did not reach statistical significance.
Women with BV or intermediate flora and a low anti-Gvh
IgA response have significantly higher concentrations of
sialidase and prolidase than do women with BV or inter-
mediate flora and a normal anti-Gvh IgA response. This
lends support to the concept that BV encompasses a spec-
trum of not only microbes but also microbial products
and host response.
Among women with BV or intermediate flora, those
women with sialidase had the highest rate of early preterm
birth in this cohort. It is biologically plausible that siali-
dase might increase the risk for preterm birth. Sialidases
cleave the terminal sialic acid from various glycoproteins,
including immunoglobulins, especially IgA. Thus, siali-
dases may potentially hamper the local mucosal immune
response.15 In addition, desialylation can alter the mucin
plug both by altering the charge potential of glycopro-
teins and by favoring further degradation by proteases.16
Persistent sialidase activity after antibiotic treatment in
pregnant women was associated with an increased risk of
preterm birth in one cohort.17 However, another study
did not demonstrate an association between midtrimester
cervical sialidase concentrations and preterm birth.18
We defined a low anti-Gvh IgA concentration in our co-
hort as below the median value for women with a normal
vaginal Gram stain and no G vaginalis on culture (≤94
mOD) and a high anti-Gvh concentration as >94 mOD.
This is a much lower cutoff value for anti-Gvh IgA than
has been used in previous studies of nonpregnant
women.11-13 There is no published information about
cervical or vaginal IgA concentrations among pregnant
women in preterm labor, so it is difficult to put this infor-
mation into context.
Women with BV or intermediate flora and a low anti-
Gvh IgA concentration have increased vaginal sialidase
and prolidase concentrations. It is plausible that sialidase
contributes to the local degradation of IgA, thus facilitat-
ing the entry of vaginal pathogenic bacteria into the
upper cervix and uterus. However, because we sampled
sialidase and IgA simultaneously, the association between
sialidase and low anti-Gvh IgA response cannot be inter-
preted as causal in this data set.
These data suggest that sialidase is associated with an
increased risk of early preterm birth among women with
BV or intermediate flora. However, although sialidase has
fairly good specificity, it does not have high sensitivity for
early preterm birth. Thus, sialidase in isolation will prob-
ably have limited usefulness as a clinical screening test.
Stated differently, although sialidase appears to increase
the risk for early preterm birth, this enzyme is not suffi-
cient to explain the entire association between BV or in-
termediate flora and early preterm birth. This implies
that there are probably other, as yet uncharacterized, vir-
ulence and/or host immune factors that contribute to ad-
verse reproductive outcomes among some women with
BV. Cervical leukocytes and epithelial cells represent an-
other potential site that is influenced by the microbes
that are present in BV and by their products. It is critical
that we learn more about the factors that contribute to
the pathogenicity of BV if we hope to devise effective pre-
vention and treatment strategies.
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